Hypertension, Pulmonary
Cardiovascular·MeSH: Hypertension, Pulmonary
Prevalence
47000.0 / 100K
Incidence
3000.0 / 100K/yr
6 drugs in development·3 companies·6 clinical trials
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| Adempas | Merck & Co., Inc. (MRK) |
Phase 3(2)
Compare drugs
Frequently asked questions
How many drugs are in development for Hypertension, Pulmonary?
BioSniper tracks 6 drugs in development for Hypertension, Pulmonary across 3 companies.
How many clinical trials target Hypertension, Pulmonary?
There are 6 clinical trials targeting Hypertension, Pulmonary tracked by BioSniper.
What is the prevalence of Hypertension, Pulmonary?
The estimated prevalence of Hypertension, Pulmonary is approximately 47000.0 per 100,000 population.
Deep-dive into Hypertension, Pulmonary
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis